Kortensi Karianga
Resident of Physical Medicine and Rehabilitation Department of the Faculty of Medicine of Sam Ratulangi University, Manado, Indonesia

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

Hasil QuickDASH Jangka Pendek setelah Rehabilitasi Berbasis ERAS pada Pasien Pasca Mastektomi Radikal Modifikasi: Studi Terkontrol Nonrandomisasi Joudy Gessal; Regina Grimonia Sompotan; Kortensi Karianga; Thomas Khosasih
Majalah Kedokteran Indonesia Vol 76 No 3 (2026): Journal of The Indonesian Medical Association - Majalah Kedokteran Indonesia, Vo
Publisher : PENGURUS BESAR IKATAN DOKTER INDONESIA (PB IDI)

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.47830/jinma-vol.76.3-2026-2076

Abstract

Introduction: Modified Radical Mastectomy (MRM) may cause postoperative upper-limb dysfunction in breast cancer patients. Enhanced Recovery After Surgery (ERAS) combined with upper-limb-specific exercise may improve shoulder functional recovery. This study aimed to evaluate the effect of ERAS combined with upper-limb-specific exercise on shoulder functional ability after MRM.Methods: This experimental pretest–posttest controlled study included 24 breast cancer patients undergoing MRM, equally divided into ERAS and Non-ERAS groups. Shoulder functional ability was assessed using the Quick-DASH Score at one and four weeks postoperatively. Data were analyzed using paired and independent t-tests.Results: The Quick-DASH Score decreased significantly in both groups. The Non-ERAS group improved from 67.08 ± 2.68 to 35.67 ± 4.98, while the ERAS group improved from 48.08 ± 6.80 to 12.50 ± 6.74, both p less than 0.001. The reduction was significantly greater in the ERAS group than in the Non-ERAS group, 35.58 ± 3.26 vs. 31.42 ± 3.18, p = 0.002.Conclusion: ERAS combined with upper-limb-specific exercise significantly improves shoulder functional ability after MRM and may be considered a perioperative rehabilitation approach for breast cancer patients.